"202 samples of suspected swine flu patients were sent to the National Centre for Disease Control in Delhi, of which reports of 118 were received," Director, Health Services, R Prasanna said at a press conference today.
"The reports confirmed that 27 of them were H1N1 positive and three of them have died so far," he said.
The official said there was enough stock of swine flu medicines in the state.
"We have abundant stocks of the (swine flu) medicines," he said, adding that 7,036 strips of 75 mg Tamiflu capsules and 264 strips of 30 mg capsules were available, alongwith 92 bottles of Tamiflu syrup.
Prasanna, however, admitted that there was a shortage of H1N1 vaccine in the state.
"There is a shortage of vaccine as a large number of people were administered it after the cases of swine flu came up. There is no need to panic as it would be available within 2-3 days," he said.
Health minister Amar Agrawal had directed the officials to take preventive measures to control the spread of the disease and make arrangements for treatment, he said.
Prasanna also advised that if symptoms of viral infection were seen, people should immediately visit the doctor, assuring that the disease was treatable with Tamiflu.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
